Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (DFPH) Total Liabilities (2020 - 2025)

Historic Total Liabilities for Oncology Institute (DFPH) over the last 6 years, with Q3 2025 value amounting to $175.9 million.

  • Oncology Institute's Total Liabilities rose 744.77% to $175.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $175.9 million, marking a year-over-year increase of 744.77%. This contributed to the annual value of $169.1 million for FY2024, which is 1111.13% up from last year.
  • Oncology Institute's Total Liabilities amounted to $175.9 million in Q3 2025, which was up 744.77% from $168.8 million recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Total Liabilities registered a high of $175.9 million during Q3 2025, and its lowest value of $19.4 million during Q1 2021.
  • Its 5-year average for Total Liabilities is $122.8 million, with a median of $146.5 million in 2023.
  • As far as peak fluctuations go, Oncology Institute's Total Liabilities skyrocketed by 51846.69% in 2022, and later crashed by 600.76% in 2023.
  • Quarter analysis of 5 years shows Oncology Institute's Total Liabilities stood at $99.3 million in 2021, then soared by 39.49% to $138.5 million in 2022, then rose by 9.91% to $152.2 million in 2023, then increased by 11.11% to $169.1 million in 2024, then rose by 4.0% to $175.9 million in 2025.
  • Its last three reported values are $175.9 million in Q3 2025, $168.8 million for Q2 2025, and $158.9 million during Q1 2025.